Niche Market Specialization: 60 Degrees Pharmaceuticals focuses on a specialized market of tropical, emerging, and biodefense infectious diseases, allowing them to cultivate deep expertise and address unmet needs often overlooked by larger pharmaceutical companies.

Proprietary Product (Arakoda): The company holds exclusive rights to Arakoda (tafenoquine) for specific prophylactic indications, offering a unique, FDA-approved, once-weekly oral malaria preventative effective against both P. falciparum and P. vivax liver stages.

Strategic Government and Military Focus: By targeting the U.S. government, particularly the Department of Defense, 60 Degrees Pharmaceuticals benefits from a stable customer base, long-term contracts, and a streamlined procurement process within a high-priority sector.